Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study Group.
Arnold AE, Serruys PW, Rutsch W, Simoons ML, de Bono DP, Tijssen JG, Lubsen J, Verstraete M. Arnold AE, et al. Among authors: lubsen j. J Am Coll Cardiol. 1991 Jan;17(1):11-21. doi: 10.1016/0735-1097(91)90699-a. J Am Coll Cardiol. 1991. PMID: 1898951 Free article. Clinical Trial.
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PA.
Arnold AE, Brower RW, Collen D, van Es GA, Lubsen J, Serruys PW, Simoons ML, Verstraete M. Arnold AE, et al. Among authors: lubsen j. J Am Coll Cardiol. 1989 Sep;14(3):581-8. doi: 10.1016/0735-1097(89)90096-x. J Am Coll Cardiol. 1989. PMID: 2504798 Free article.
Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction--a quantitative coronary angiography study of a randomized trial.
Serruys PW, Arnold AE, Brower RW, de Bono DP, Bokslag M, Lubsen J, Reiber JH, Rutsch WR, Uebis R, Vahanian A, et al. Serruys PW, et al. Among authors: lubsen j. Eur Heart J. 1987 Nov;8(11):1172-81. doi: 10.1093/oxfordjournals.eurheartj.a062189. Eur Heart J. 1987. PMID: 3121334 Clinical Trial.
Thrombolytic therapy for acute coronary thrombosis.
Simoons ML, Lubsen J, Serruys PW, Hugenholtz PG. Simoons ML, et al. Among authors: lubsen j. Eur Heart J. 1987 Sep;8 Suppl F:78-87. doi: 10.1093/eurheartj/8.suppl_f.78. Eur Heart J. 1987. PMID: 3311764 Review. No abstract available.
164 results